Prognostic significance of human papillomavirus (HPV) status and expression of selected markers (HER2/neu, EGFR, VEGF, CD34, p63, p53 and Ki67/MIB-1) on outcome after (chemo-) radiotherapy in patients with squamous cell carcinoma of uterine cervix (Q38395430)

From Wikidata

Jump to navigation Jump to search

scientific article published on 03 August 2013

Language	Label	Description	Also known as
English	Prognostic significance of human papillomavirus (HPV) status and expression of selected markers (HER2/neu, EGFR, VEGF, CD34, p63, p53 and Ki67/MIB-1) on outcome after (chemo-) radiotherapy in patients with squamous cell carcinoma of uterine cervix	scientific article published on 03 August 2013

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Prognostic significance of human papillomavirus (HPV) status and expression of selected markers (HER2/neu, EGFR, VEGF, CD34, p63, p53 and Ki67/MIB-1) on outcome after (chemo-) radiotherapy in patients with squamous cell carcinoma of uterine cervix (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

author name string

Milan Vosmik

1

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Jan Laco

2

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Igor Sirak

3

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Martin Beranek

4

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Eva Hovorkova

5

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Hana Vosmikova

6

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Monika Drastikova

7

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Zdenek Zoul

9

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Karel Odrazka

10

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Jiri Petera

11

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

publication date

3 August 2013

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Pathology Oncology Research

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

20

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

131-137

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9674-5

21 January 2018

Severe late toxicities following concomitant chemoradiotherapy compared to radiotherapy alone in cervical cancer: an inter-era analysis

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9674-5

21 January 2018

Molecular predictive factors of outcome of radiotherapy in cervical cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9674-5

21 January 2018

HPV genotyping in cervical cancer in Northern Thailand: adapting the linear array HPV assay for use on paraffin-embedded tissue

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9674-5

21 January 2018

Human papilloma virus (HPV) DNA associated with prognosis of cervical cancer after radiotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9674-5

21 January 2018

Human papillomavirus status in advanced cervical cancer: predictive and prognostic significance for curative radiation treatment.

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9674-5

21 January 2018

Correlation between human epidermal growth factor receptor family (EGFR, HER2, HER3, HER4), phosphorylated Akt (P-Akt), and clinical outcomes after radiation therapy in carcinoma of the cervix

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9674-5

21 January 2018

Correlation among six biologic factors (p53, p21(WAF1), MIB-1, EGFR, HER2, and Bcl-2) and clinical outcomes after curative chemoradiation therapy in squamous cell cervical cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9674-5

21 January 2018

EGFR and HER2 expression in primary cervical cancers and corresponding lymph node metastases: implications for targeted radiotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9674-5

21 January 2018

Expression of epidermal growth factor receptor (EGFR) and activated EGFR predict poor response to (chemo)radiation and survival in cervical cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9674-5

21 January 2018

P63 and EGFR as prognostic predictors in stage IIB radiation-treated cervical squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9674-5

21 January 2018

Vascular endothelial growth factor (VEGF) expression is a prognostic factor for radiotherapy outcome in advanced carcinoma of the cervix

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9674-5

21 January 2018

The prognostic effect of VEGF expression in squamous cell carcinoma of the cervix treated with radiation therapy alone

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9674-5

21 January 2018

Epidermal growth factor receptor (EGFR) and vascular endothelial growth factor (VEGF) negatively affect overall survival in carcinoma of the cervix treated with radiotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9674-5

21 January 2018

Markers of angiogenesis in high-risk, early-stage cervical cancer: A Gynecologic Oncology Group study

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9674-5

21 January 2018

The effects of p53 status and human papillomavirus infection on the clinical outcome of patients with stage IIIB cervical carcinoma treated with radiation therapy alone.

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9674-5

21 January 2018

Apoptosis, intrinsic radiosensitivity and prediction of radiotherapy response in cervical carcinoma.

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9674-5

21 January 2018

MIB1 growth fraction is not related to prognosis in cervical squamous cell carcinoma treated with radiotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/23913252

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Do HPV-negative cervical carcinomas exist??revisited

1 reference

https://pubmed.ncbi.nlm.nih.gov/23913252

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Extended field radiotherapy and high-dose brachytherapy combined with chemotherapy in patients with locally advanced cervical carcinoma]

1 reference

https://pubmed.ncbi.nlm.nih.gov/23913252

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessment of proliferation index with MIB-1 as a prognostic factor in radiation therapy for cervical cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23913252

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of p53 and Bcl-2 expression as prognostic markers in invasive cervical carcinoma stage IIb/III patients treated by radiotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/23913252

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The influence of cisplatin dose upon survival in concurrent chemoradiotherapy of locally advanced cervical carcinoma with weekly cisplatin

1 reference

https://pubmed.ncbi.nlm.nih.gov/23913252

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemotherapy intensity importance in concurrent chemoradiotherapy of locally advanced cervical cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23913252

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunohistochemical prediction of radiation response and local control in radiation therapy for cervical cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23913252

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic significance of c-erbB-2/HER2 expression in advanced uterine cervical carcinoma with para-aortic lymph node metastasis treated with radiation therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/23913252

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predicting the outcome of squamous cell carcinoma of the uterine cervix using combinations of individual tumor marker expressions

1 reference

https://pubmed.ncbi.nlm.nih.gov/23913252

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of p27 and p53 in cervical squamous cell carcinoma patients treated with radiotherapy alone: radiotherapeutic effect and prognosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23913252

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic significance of immunohistochemically detected p53 protein expression in stage IIIB squamous cell carcinoma of the uterine cervix treated with radiation therapy alone

1 reference

https://pubmed.ncbi.nlm.nih.gov/23913252

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumour-proliferative fraction and growth factor expression as markers of tumour response to radiotherapy in cancer of the uterine cervix

1 reference

https://pubmed.ncbi.nlm.nih.gov/23913252

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic significance of Bax, Bcl-2, and p53 expressions in cervical squamous cell carcinoma treated by radiotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/23913252

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12253-013-9674-5

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38395430&oldid=2201655062"